CRNKL1 Is a Highly Selective Regulator of Intron-Retaining HIV-1 and Cellular mRNAs.


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
19 01 2021
Historique:
entrez: 20 1 2021
pubmed: 21 1 2021
medline: 11 9 2021
Statut: epublish

Résumé

The HIV-1 Rev protein is a nuclear export factor for unspliced and incompletely spliced HIV-1 RNAs. Without Rev, these intron-retaining RNAs are trapped in the nucleus. A genome-wide screen identified nine proteins of the spliceosome, which all enhanced expression from the HIV-1 unspliced RNA after CRISPR/Cas knockdown. Depletion of DHX38, WDR70, and four proteins of the Prp19-associated complex (ISY1, BUD31, XAB2, and CRNKL1) resulted in a more than 20-fold enhancement of unspliced HIV-1 RNA levels in the cytoplasm. Targeting of CRNKL1, DHX38, and BUD31 affected nuclear export efficiencies of the HIV-1 unspliced RNA to a much larger extent than splicing. Transcriptomic analyses further revealed that CRNKL1 also suppresses cytoplasmic levels of a subset of cellular mRNAs, including some with selectively retained introns. Thus, CRNKL1-dependent nuclear retention is a novel cellular mechanism for the regulation of cytoplasmic levels of intron-retaining HIV-1 mRNAs, which HIV-1 may have harnessed to direct its complex splicing pattern.

Identifiants

pubmed: 33468685
pii: mBio.02525-20
doi: 10.1128/mBio.02525-20
pmc: PMC7845644
pii:
doi:

Substances chimiques

BUD31 protein, human 0
CRNKL1 protein, human 0
ISY1 protein, human 0
Nuclear Proteins 0
RNA Splicing Factors 0
RNA, Messenger 0
RNA, Small Interfering 0
RNA, Viral 0
XAB2 protein, human 0
rev Gene Products, Human Immunodeficiency Virus 0
rev protein, Human Immunodeficiency Virus-1 0
DHX38 protein, human EC 3.6.1.-
DEAD-box RNA Helicases EC 3.6.4.13

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2021 Xiao et al.

Références

J Virol. 2015 Apr;89(7):3557-67
pubmed: 25589658
Nat Methods. 2014 Aug;11(8):783-784
pubmed: 25075903
Curr Biol. 1996 Mar 1;6(3):315-24
pubmed: 8805248
RNA. 2005 May;11(5):533-57
pubmed: 15840809
Hum Gene Ther. 2000 Nov 20;11(17):2403-13
pubmed: 11096444
J Mol Biol. 2018 Sep 14;430(18 Pt B):3111-3128
pubmed: 30131116
J Cell Biol. 2013 Oct 14;203(1):149-64
pubmed: 24127217
J Gen Virol. 2010 Aug;91(Pt 8):1893-1897
pubmed: 20538907
J Biol Chem. 2010 May 28;285(22):16495-503
pubmed: 20353939
Cell Cycle. 2015;14(12):1873-83
pubmed: 25892155
J Virol. 2004 Feb;78(4):2082-7
pubmed: 14747573
Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8314-8
pubmed: 8078879
Cell Host Microbe. 2008 Jun 12;3(6):388-98
pubmed: 18541215
Neuron. 2006 Dec 21;52(6):969-80
pubmed: 17178401
Genes Dev. 1991 Jun;5(6):1080-91
pubmed: 2044955
Nature. 2016 Dec 22;540(7634):593-596
pubmed: 27951587
PLoS Pathog. 2007 Apr;3(4):e54
pubmed: 17432934
Science. 2014 Jan 3;343(6166):84-87
pubmed: 24336571
EMBO J. 1997 Aug 1;16(15):4531-9
pubmed: 9303297
J Comput Biol. 2004;11(2-3):377-94
pubmed: 15285897
Cold Spring Harb Perspect Med. 2012 Feb;2(2):a006916
pubmed: 22355797
Mol Cell Biol. 1993 Oct;13(10):6180-9
pubmed: 8105371
RNA. 2011 Jul;17(7):1344-56
pubmed: 21613532
Nat Rev Drug Discov. 2017 Nov;16(11):773-786
pubmed: 29026209
PLoS One. 2011 Feb 28;6(2):e16719
pubmed: 21386897
J Mol Biol. 1996 Mar 29;257(2):246-64
pubmed: 8609621
Hum Genet. 2017 Sep;136(9):1043-1057
pubmed: 28391524
Genome Res. 2014 Nov;24(11):1774-86
pubmed: 25258385
Cell Rep. 2015 Feb 3;10(4):586-99
pubmed: 25620704
Biochim Biophys Acta. 2012 Jun;1819(6):507-13
pubmed: 22178508
Cell. 2018 Dec 13;175(7):1958-1971.e15
pubmed: 30449619
PLoS Comput Biol. 2010 Nov 24;6(11):e1001016
pubmed: 21124863
Nat Biotechnol. 2019 Aug;37(8):907-915
pubmed: 31375807
Annu Rev Microbiol. 1998;52:491-532
pubmed: 9891806
Science. 2015 Nov 27;350(6264):1096-101
pubmed: 26472758
Biochem Biophys Res Commun. 2018 Mar 4;497(2):597-604
pubmed: 29454968
Cell. 2017 May 18;169(5):918-929.e14
pubmed: 28502770
Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1256-60
pubmed: 8108397
J Virol. 1991 Oct;65(10):5305-13
pubmed: 1895385
Virus Genes. 1996;12(3):275-85
pubmed: 8883365
J Virol. 1998 Apr;72(4):2855-64
pubmed: 9525605
EMBO J. 2004 Dec 8;23(24):4847-56
pubmed: 15565172
Nucleic Acids Res. 2017 Oct 13;45(18):10350-10368
pubmed: 28977640
J Virol. 2010 Jul;84(13):6598-604
pubmed: 20427541
RNA Biol. 2009 Apr-Jun;6(2):149-52
pubmed: 19229134
J Virol. 2015 Sep;89(18):9601-15
pubmed: 26178996
Retrovirology. 2011 Jul 20;8:61
pubmed: 21771347
Science. 2018 Feb 2;359(6375):537-545
pubmed: 29301961
Genes Cells. 2011 Oct;16(10):1035-49
pubmed: 21929696
Science. 2019 Feb 15;363(6428):710-714
pubmed: 30705154
J Biol Chem. 2003 Jan 10;278(2):1086-93
pubmed: 12370191
Virology. 2013 Jan 20;435(2):329-40
pubmed: 23158102
Nat Commun. 2020 Jun 9;11(1):2907
pubmed: 32518300
Proc Natl Acad Sci U S A. 2012 Apr 10;109(15):5651-6
pubmed: 22451905
Mol Cell Biol. 2003 Sep;23(18):6618-30
pubmed: 12944487
Genome Biol. 2014;15(12):554
pubmed: 25476604
Genes Dev. 2011 Jun 1;25(11):1147-58
pubmed: 21576257
mBio. 2018 Nov 13;9(6):
pubmed: 30425153
J Virol. 2004 May;78(9):4389-96
pubmed: 15078920
PLoS Genet. 2018 Jul 3;14(7):e1007473
pubmed: 29969449
Science. 2017 Jan 13;355(6321):149-155
pubmed: 27980089
Cold Spring Harb Protoc. 2010 Jun;2010(6):pdb.prot5439
pubmed: 20516177
Mol Cell Biol. 2000 Jun;20(12):4181-7
pubmed: 10825183
BMC Bioinformatics. 2011 Aug 04;12:323
pubmed: 21816040
Curr HIV Res. 2009 Jan;7(1):91-100
pubmed: 19149558
J Virol. 1991 Nov;65(11):5732-43
pubmed: 1656066
Bioinformatics. 2011 Nov 1;27(21):2987-93
pubmed: 21903627
Proc Natl Acad Sci U S A. 1989 Aug;86(16):6111-5
pubmed: 2788283
Cell Rep. 2012 May 31;1(5):543-56
pubmed: 22832277
Nucleic Acids Res. 2015 Apr 30;43(8):4249-61
pubmed: 25845599
J Cell Biol. 2017 Jul 3;216(7):1875-1877
pubmed: 28600433
Curr Opin Cell Biol. 2003 Jun;15(3):326-31
pubmed: 12787775
Curr Pharm Des. 2017;23(28):4079-4090
pubmed: 28641539
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Nucleic Acids Res. 2019 Sep 5;47(15):8239-8254
pubmed: 31216022
RNA Biol. 2016;13(2):128-33
pubmed: 26479714
Retrovirology. 2006 Mar 17;3:18
pubmed: 16545126
J Virol. 2000 Nov;74(22):10822-6
pubmed: 11044131
RNA Biol. 2013 Nov;10(11):1714-25
pubmed: 24157614
Nucleic Acids Res. 2013 Feb 1;41(4):2517-25
pubmed: 23275560
Retrovirology. 2011 Jul 20;8:60
pubmed: 21771346
Biochim Biophys Acta. 2002 Jul 19;1576(3):287-97
pubmed: 12084575
Curr Protoc Hum Genet. 2015 Oct 06;87:11.16.1-11.16.14
pubmed: 26439713
Science. 2016 Sep 9;353(6304):1101-2
pubmed: 27609877
Biochim Biophys Acta. 2013 Oct;1833(10):2126-34
pubmed: 23742842
J Clin Invest. 2009 Nov;119(11):3473-86
pubmed: 19805909
J Virol. 2012 Mar;86(6):2990-3002
pubmed: 22258250
Mol Biol Evol. 2017 Oct 1;34(10):2453-2468
pubmed: 28957512
Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3386-91
pubmed: 18287003
Nature. 1988 Sep 8;335(6186):181-3
pubmed: 3412474
Nucleic Acids Res. 2014 Jun;42(10):6645-58
pubmed: 24753416
mBio. 2013 Jan 29;4(1):e00596-12
pubmed: 23362321
Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):12039-43
pubmed: 10518572
Cell. 2004 Jan 9;116(1):63-73
pubmed: 14718167
Mol Cell. 2011 Oct 7;44(1):108-19
pubmed: 21981922
RNA. 2015 Sep;21(9):1521-31
pubmed: 26179515
Mol Cell. 2019 Feb 21;73(4):803-814.e6
pubmed: 30639243

Auteurs

Han Xiao (H)

Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.

Emanuel Wyler (E)

Berlin Institute for Medical Systems Biology, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.

Miha Milek (M)

Berlin Institute for Medical Systems Biology, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.

Bastian Grewe (B)

Department of Molecular and Medical Virology, Ruhr-University, Bochum, Germany.

Philipp Kirchner (P)

Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.

Arif Ekici (A)

Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.

Ana Beatriz Oliveira Villela Silva (ABOV)

Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.

Doris Jungnickl (D)

Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.

Florian Full (F)

Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.

Marco Thomas (M)

Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.

Markus Landthaler (M)

Berlin Institute for Medical Systems Biology, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
IRI Life Sciences, Institute für Biologie, Humboldt Universität zu Berlin, Berlin, Germany.

Armin Ensser (A)

Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.

Klaus Überla (K)

Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany klaus.ueberla@fau.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH